Hanmi Pharm Co., a Korean drugmaker, said on March 26 it plans to split into holding and operating entities in an effort to streamline the corporate structure from this July.
A board of directors finalized the plan in the day, Hanmi said in a regulatory filing, and the decision will be decided at a shareholders' meeting scheduled on May 28.
Hanmi Pharm will be separated into two firms - ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.